One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
Identifieur interne : 000346 ( Main/Corpus ); précédent : 000345; suivant : 000347One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
Auteurs : Charlotte Moss ; Saoirse Dolly ; Beth Russell ; Mary Lei ; Sharmista Ghosh ; Sophie Papa ; Richard Sullivan ; Mieke Van Hemelrijck ; Anne RiggSource :
- Cancer control : journal of the Moffitt Cancer Center [ 1526-2359 ]
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Betacoronavirus (isolation & purification), Cancer Care Facilities (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (epidemiology), Female (MeSH), Humans (MeSH), London (epidemiology), Male (MeSH), Middle Aged (MeSH), Neoplasms (epidemiology), Neoplasms (therapy), Pandemics (MeSH), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Prevalence (MeSH).
- MESH :
- geographic , epidemiology : London.
- diagnosis : Coronavirus Infections, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Neoplasms, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- therapy : Neoplasms.
- Adult, Aged, Cancer Care Facilities, Female, Humans, Male, Middle Aged, Pandemics, Prevalence.
Abstract
COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.
DOI: 10.1177/1073274820950844
PubMed: 32885663
Links to Exploration step
pubmed:32885663Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</title><author><name sortKey="Moss, Charlotte" sort="Moss, Charlotte" uniqKey="Moss C" first="Charlotte" last="Moss">Charlotte Moss</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Dolly, Saoirse" sort="Dolly, Saoirse" uniqKey="Dolly S" first="Saoirse" last="Dolly">Saoirse Dolly</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Russell, Beth" sort="Russell, Beth" uniqKey="Russell B" first="Beth" last="Russell">Beth Russell</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Lei, Mary" sort="Lei, Mary" uniqKey="Lei M" first="Mary" last="Lei">Mary Lei</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Ghosh, Sharmista" sort="Ghosh, Sharmista" uniqKey="Ghosh S" first="Sharmista" last="Ghosh">Sharmista Ghosh</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Sullivan, Richard" sort="Sullivan, Richard" uniqKey="Sullivan R" first="Richard" last="Sullivan">Richard Sullivan</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Van Hemelrijck, Mieke" sort="Van Hemelrijck, Mieke" uniqKey="Van Hemelrijck M" first="Mieke" last="Van Hemelrijck">Mieke Van Hemelrijck</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Rigg, Anne" sort="Rigg, Anne" uniqKey="Rigg A" first="Anne" last="Rigg">Anne Rigg</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Jul-Aug</date><idno type="RBID">pubmed:32885663</idno><idno type="pmid">32885663</idno><idno type="doi">10.1177/1073274820950844</idno><idno type="wicri:Area/Main/Corpus">000346</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000346</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</title><author><name sortKey="Moss, Charlotte" sort="Moss, Charlotte" uniqKey="Moss C" first="Charlotte" last="Moss">Charlotte Moss</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Dolly, Saoirse" sort="Dolly, Saoirse" uniqKey="Dolly S" first="Saoirse" last="Dolly">Saoirse Dolly</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Russell, Beth" sort="Russell, Beth" uniqKey="Russell B" first="Beth" last="Russell">Beth Russell</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Lei, Mary" sort="Lei, Mary" uniqKey="Lei M" first="Mary" last="Lei">Mary Lei</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Ghosh, Sharmista" sort="Ghosh, Sharmista" uniqKey="Ghosh S" first="Sharmista" last="Ghosh">Sharmista Ghosh</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Papa, Sophie" sort="Papa, Sophie" uniqKey="Papa S" first="Sophie" last="Papa">Sophie Papa</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Sullivan, Richard" sort="Sullivan, Richard" uniqKey="Sullivan R" first="Richard" last="Sullivan">Richard Sullivan</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Van Hemelrijck, Mieke" sort="Van Hemelrijck, Mieke" uniqKey="Van Hemelrijck M" first="Mieke" last="Van Hemelrijck">Mieke Van Hemelrijck</name><affiliation><nlm:affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Rigg, Anne" sort="Rigg, Anne" uniqKey="Rigg A" first="Anne" last="Rigg">Anne Rigg</name><affiliation><nlm:affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Cancer control : journal of the Moffitt Cancer Center</title><idno type="eISSN">1526-2359</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Betacoronavirus (isolation & purification)</term><term>Cancer Care Facilities (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (epidemiology)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>London (epidemiology)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Neoplasms (epidemiology)</term><term>Neoplasms (therapy)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (epidemiology)</term><term>Prevalence (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>London</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Neoplasms</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Cancer Care Facilities</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pandemics</term><term>Prevalence</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32885663</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-2359</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>3</Issue><PubDate><MedlineDate>2020 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Cancer control : journal of the Moffitt Cancer Center</Title><ISOAbbreviation>Cancer Control</ISOAbbreviation></Journal><ArticleTitle>One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.</ArticleTitle><Pagination><MedlinePgn>1073274820950844</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/1073274820950844</ELocationID><Abstract><AbstractText>COVID-19 has forced governments to make drastic changes to healthcare systems. To start making informed decisions about cancer care, we need to understand the scale of COVID-19 infection. Therefore, we introduced swab testing for patients visiting Guy's Cancer Centre. Our Centre is one of the largest UK Cancer Centers at the epicenter of the UK COVID-19 epidemic. The first COVID-19 positive cancer patient was reported on 29 February 2020. We analyzed data from 7-15 May 2020 for COVID-19 tests in our cancer patients. 2,647 patients attended for outpatient, chemotherapy, or radiotherapy appointments. 654 were swabbed for COVID-19 (25%). Of those tested, 9 were positive for COVID-19 (1.38%) of which 7 were asymptomatic. Cancer service providers will need to understand their local cancer population prevalence. The absolute priority is that cancer patients have the confidence to attend hospitals and be reassured that they will be treated in a COVID-19 managed environment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moss</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dolly</LastName><ForeName>Saoirse</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Sharmista</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papa</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-7317-0858</Identifier><AffiliationInfo><Affiliation>Faculty of Life Sciences and Medicine, Translational Oncology and Urology Research (TOUR), 4616King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rigg</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Oncology, 8945Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Guy’s Cancer Real World Evidence Programme</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cancer Control</MedlineTA><NlmUniqueID>9438457</NlmUniqueID><ISSNLinking>1073-2748</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002173" MajorTopicYN="N">Cancer Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008131" MajorTopicYN="N" Type="Geographic">London</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">UK</Keyword><Keyword MajorTopicYN="N">cancer recovery</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32885663</ArticleId><ArticleId IdType="doi">10.1177/1073274820950844</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidSeniorV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000346 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000346 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidSeniorV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32885663
|texte= One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32885663" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidSeniorV1
| This area was generated with Dilib version V0.6.37. |  |